Multiple myeloma is a type of cancer characterized by the uncontrolled proliferation of clonal plasma cells, which leads to organ dysfunction and, eventually, death. There were more than 33,000 ...

For decades, the United States has led the world in pharmaceutical innovation – developing drugs that combat cancer, heart ...

NVIDIA GTC ? Phison Electronics (8299TT), a leading innovator in NAND flash technologies, today announced an array of expanded capabilities on aiDAPTIV+, the affordable AI training and inferencing ...

Leading global charity Made By Dyslexia today launches the third season of its Lessons in Dyslexic Thinking podcast, sharing ...

According to a new market research report titled, "Cyber-Physical Systems (CPS) Market in Manufacturing Size, Share, Forecast ...

“Switching horses midstream” is an idiom that means to abruptly change leaders or strategies in the middle of a crucial task, often suggesting that such a change is not a good idea and could lead to ...

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of ...

The global Central Lab Services/Clinical Trial Lab Services Market, valued at US$5.64 billion in 2024, is forecasted to grow at a robust CAGR ...

To tackle the inequity in medication access, a societal issue especially in developing nations, a team of undergraduate student-researchers at the University of Ottawa has developed a new ...

Contract Development and Manufacturing Organizations (CDMOs) enhance drug discovery by providing essential services that reduce costs and accelerate production.

SeaStar Medical (Nasdaq: ICU) has been selected to receive the 2025 Corporate Innovator Award from the National Kidney Foundation (NKF) at the 2025 Spring Clinical Meetings in Boston.